Intel (INTC) expanded its originally planned $15 billion stock offering to $20 billion, priced at $95 per share, about a 6.5% discount to the market price 📉. The money is mainly not for “firefighting,” but to “stock up on ammunition” ahead of the AI capital expenditure upswing: the company’s 2026 capital expenditure guidance has been raised from $18 billion to more than $20 billion, and 2027 will be “significantly higher” as well. Combined with a cumulative free cash flow shortfall of up to $44 billion from 2022 to 2025, further borrowing capacity is constrained, making equity financing the lowest-cost option.
Near term 📉: the offering dilutes earnings per share. Wall Street firms such as Stifel and Mizuho have lowered their target prices one after another, while Rosenblatt keeps a sell rating. The stock fell more than 4% in a single day, reflecting market concerns about dilution.
Long term 📈, but with strong disagreement: AI agents are driving a surge in CPU demand that has already exceeded existing production capacity. If Intel can secure external foundry orders from TSM for its advanced nodes (18A/14A), and pair that with U.S. government investment as a form of endorsement, Intel has a chance to regain a foothold in the AI compute landscape and compete against Nvidia’s (NVDA) ecosystem advantage. However, the foundry business still loses billions of dollars per quarter. If it can’t land major customers before 14A reaches mass production by 2028, this $20 billion financing could turn into “high-level dilution.”
Raising funds to expand capacity during the window when the stock has doubled within the year is a rational move. It faces short-term pressure 📉 but looks favorable long term if execution goes well 📈—a high-risk bet on a “process-node inflection point.” #英特尔拟扩大股票发行募约200亿美元
$NVDA
$TSM
$INTC
Near term 📉: the offering dilutes earnings per share. Wall Street firms such as Stifel and Mizuho have lowered their target prices one after another, while Rosenblatt keeps a sell rating. The stock fell more than 4% in a single day, reflecting market concerns about dilution.
Long term 📈, but with strong disagreement: AI agents are driving a surge in CPU demand that has already exceeded existing production capacity. If Intel can secure external foundry orders from TSM for its advanced nodes (18A/14A), and pair that with U.S. government investment as a form of endorsement, Intel has a chance to regain a foothold in the AI compute landscape and compete against Nvidia’s (NVDA) ecosystem advantage. However, the foundry business still loses billions of dollars per quarter. If it can’t land major customers before 14A reaches mass production by 2028, this $20 billion financing could turn into “high-level dilution.”
Raising funds to expand capacity during the window when the stock has doubled within the year is a rational move. It faces short-term pressure 📉 but looks favorable long term if execution goes well 📈—a high-risk bet on a “process-node inflection point.” #英特尔拟扩大股票发行募约200亿美元
$NVDA
$TSM
$INTC